A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether oral rucaparib is effective in the
treatment of patients with locally advanced or metastatic pancreatic cancer and a known
deleterious BRCA mutation.